Basic Information
RNALocate ID: | RLID:11001641 |
RNA Symbol: | hsa-let-7i-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-let-7i |
RNA ID: | miRBase:MIMAT0000415 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 20976003 |
Tissue/Cell Line: | Breast cancer cell line (MCF-7) |
Method: | Microarray |
Description: | Because of the suggested roles of extracellular miRNAs in signaling and diagnosis, we investigated whether the intracellular and extracellular miRNA composition are the same. To answer this question, we performed microRNA microarray analyses of MCF7 cellular (c) and extracellular (x) RNAs (Figure 2A), and found that about 66% of the released miRNAs are at an abundance that closely reflects the cellular miRNA abundance (Figures 2B and 2C). This finding is in agreement with a model wherein most, but not all miRNAs are released passively by mass action. Data are collected from Figure 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001705 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001706 | Cytoplasm | HeLa cells | 22058130 |
RLID:01001707 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001708 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001709 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001710 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001711 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001712 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001713 | Nucleus | HeLa cells | 22058130 |
RLID:11001639 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
RLID:11001640 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
RLID:11001642 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001643 | Exosome | Brain tissue | 23382797 |
RLID:11001644 | Exosome | Plasma | 23663360 |
RLID:11001645 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001646 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11001647 | Microvesicle | Plasma | 23077538 |
RLID:11001648 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001649 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000069 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000343 | Microvesicle | Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-let-7i-5p | Oral squamous cell carcinoma | MNDR-E-MI-02201 |
MNDR | hsa-let-7i-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-02202 |
MNDR | hsa-let-7i-5p | Lymphoma | MNDR-E-MI-02203 |
MNDR | hsa-let-7i-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-02204 |
MNDR | hsa-let-7i-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-02205 |
MNDR | hsa-let-7i-5p | Her2-receptor positive breast cancer | MNDR-E-MI-02206 |
MNDR | hsa-let-7i-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-02207 |
MNDR | hsa-let-7i-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-02208 |
MNDR | hsa-let-7i-5p | Prostate cancer | MNDR-E-MI-02209 |
MNDR | hsa-let-7i-5p | Gastric cancer | MNDR-E-MI-02210 |
MNDR | hsa-let-7i-5p | Gastric lymphoma | MNDR-E-MI-02211 |
MNDR | hsa-let-7i-5p | Alzheimer disease | MNDR-E-MI-02212 |
MNDR | hsa-let-7i-5p | Malaria | MNDR-E-MI-02213 |
MNDR | hsa-let-7i-5p | Leukemia | MNDR-E-MI-02214 |
MNDR | hsa-let-7i-5p | Cardiovascular disease | MNDR-E-MI-02215 |
MNDR | hsa-let-7i-5p | Carotid stenosis | MNDR-E-MI-02216 |
MNDR | hsa-let-7i-5p | Lung cancer | MNDR-E-MI-02217 |
MNDR | hsa-let-7i-5p | Metabolic syndrome x | MNDR-E-MI-02218 |
MNDR | hsa-let-7i-5p | Parkinson disease | MNDR-E-MI-02219 |
MNDR | hsa-let-7i-5p | Breast cancer | MNDR-E-MI-02220 |
MNDR | hsa-let-7i-5p | Thyroid cancer | MNDR-E-MI-02221 |
MNDR | hsa-let-7i-5p | Pancreatic cancer | MNDR-E-MI-02222 |
MNDR | hsa-let-7i-5p | Melanoma | MNDR-E-MI-02223 |
MNDR | hsa-let-7i-5p | Epithelial ovarian cancer | MNDR-E-MI-02224 |
MNDR | hsa-let-7i-5p | Nephroblastoma | MNDR-E-MI-02225 |
MNDR | hsa-let-7i-5p | Colon cancer | MNDR-E-MI-02226 |
MNDR | hsa-let-7i-5p | Familial ovarian cancer | MNDR-E-MI-02227 |
MNDR | hsa-let-7i-5p | Carcinoma ductal breast | MNDR-E-MI-02228 |
MNDR | hsa-let-7i-5p | Glioblastoma | MNDR-E-MI-02229 |
MNDR | hsa-let-7i-5p | Glioma | MNDR-E-MI-02230 |
MNDR | hsa-let-7i-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-02231 |
MNDR | hsa-let-7i-5p | Chordoma | MNDR-E-MI-02232 |
MNDR | hsa-let-7i-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-02233 |
MNDR | hsa-let-7i-5p | Osteosarcoma | MNDR-E-MI-02234 |
MNDR | hsa-let-7i-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-02235 |
MNDR | hsa-let-7i-5p | Liver cancer | MNDR-E-MI-02236 |
MNDR | hsa-let-7i-5p | Uterine cancer | MNDR-E-MI-02237 |
MNDR | hsa-let-7i-5p | Cervical adenocarcinoma | MNDR-E-MI-02238 |
MNDR | hsa-let-7i-5p | Gastric adenocarcinoma | MNDR-E-MI-02239 |
MNDR | hsa-let-7i-5p | Cervical squamous cell carcinoma | MNDR-E-MI-02240 |
MNDR | hsa-let-7i-5p | Lung squamous cell carcinoma | MNDR-E-MI-02241 |
MNDR | hsa-let-7i-5p | Lung adenocarcinoma | MNDR-E-MI-02242 |
MNDR | hsa-let-7i-5p | Adrenocortical cancer | MNDR-E-MI-02243 |
MNDR | hsa-let-7i-5p | Thyroid carcinoma | MNDR-E-MI-02244 |
MNDR | hsa-let-7i-5p | Tuberculosis | MNDR-E-MI-02245 |
MNDR | hsa-let-7i-5p | Bladder urothelial carcinoma | MNDR-E-MI-02246 |
MNDR | hsa-let-7i-5p | Pancreatic adenocarcinoma | MNDR-E-MI-02247 |
MNDR | hsa-let-7i-5p | Carcinoma renal cell | MNDR-E-MI-02248 |
MNDR | hsa-let-7i-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-02249 |
MNDR | hsa-let-7i-5p | Clear cell renal cell carcinoma | MNDR-E-MI-02250 |
MNDR | hsa-let-7i-5p | Biliary tract cancer | MNDR-E-MI-02251 |
MNDR | hsa-let-7i-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-02252 |
MNDR | hsa-let-7i-5p | Cholangiocarcinoma | MNDR-E-MI-02253 |
MNDR | hsa-let-7i-5p | Esophageal cancer | MNDR-E-MI-02254 |
MNDR | hsa-let-7i-5p | Liver cirrhosis | MNDR-E-MI-02255 |
MNDR | hsa-let-7i-5p | Lung small cell carcinoma | MNDR-E-MI-02256 |
MNDR | hsa-let-7i-5p | T acute lymphoblastic leukemia | MNDR-E-MI-02257 |
MNDR | hsa-let-7i-5p | Acute t cell leukemia | MNDR-E-MI-02258 |
MNDR | hsa-let-7i-5p | Fibromyalgia | MNDR-E-MI-02259 |
MNDR | hsa-let-7i-5p | Adenoma | MNDR-E-MI-02260 |
MNDR | hsa-let-7i-5p | Breast invasive carcinoma | MNDR-E-MI-02261 |
MNDR | hsa-let-7i-5p | Early hepatocellular carcinoma | MNDR-E-MI-02262 |
MNDR | hsa-let-7i-5p | Familiar ovarian carcinoma | MNDR-E-MI-02263 |
MNDR | hsa-let-7i-5p | B-cell lymphoma | MNDR-E-MI-02264 |
MNDR | hsa-let-7i-5p | Rheumatoid arthritis | MNDR-E-MI-02265 |
MNDR | hsa-let-7i-5p | T-cell leukemia | MNDR-E-MI-02266 |
MNDR | hsa-let-7i-5p | Retinoblastoma | MNDR-E-MI-02267 |
MNDR | hsa-let-7i-5p | Neuroblastoma | MNDR-E-MI-02268 |
MNDR | hsa-let-7i-5p | Neuromyelitis optica | MNDR-E-MI-02269 |
MNDR | hsa-let-7i-5p | Acute myelogenous leukemia | MNDR-E-MI-02270 |
MNDR | hsa-let-7i-5p | Colorectal cancer | MNDR-E-MI-02271 |
MNDR | hsa-let-7i-5p | Nasopharynx carcinoma | MNDR-E-MI-02272 |
MNDR | hsa-let-7i-5p | Multiple myeloma | MNDR-E-MI-02273 |
MNDR | hsa-let-7i-5p | Acute lymphocytic leukemia | MNDR-E-MI-02274 |
MNDR | hsa-let-7i-5p | Epithelial ovarian carcinoma | MNDR-E-MI-02275 |
MNDR | hsa-let-7i-5p | Nasopharyngeal cancer | MNDR-E-MI-02276 |
MNDR | hsa-let-7i-5p | Prostatic neoplasms | MNDR-E-MI-02277 |
MNDR | hsa-let-7i-5p | Aldh1+ cancer stem cells | MNDR-E-MI-02278 |
MNDR | hsa-let-7i-5p | Low grade dysplastic nodule | MNDR-E-MI-02279 |
MNDR | hsa-let-7i-5p | Tubulovillous adenoma | MNDR-E-MI-02280 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCC10 | Homo sapiens | RR00023407 |
TOP